International AIDS Vaccine Initiative & Richard Hatchett
3 shared events · Importance 3 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Tech
International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative (IAVI) received an initial $3.2 million from CEPI to develop a single-dose Bundibugyo vaccine candidate using technology similar to Merck's Ervebo.
Richard Hatchett: Dr. Richard Hatchett>>>, CEO of Coalition for Epidemic Preparedness Innovations>>>, emphasized the urgency of funding to advance safe and effective vaccines against the Bundibugyo virus.
May 22, 2026 · 36 articles
International
International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is working on a modified version of the Zaire Ebola vaccine to fight the Bundibugyo strain, with experimental jabs showing nearly 100% protection in monkeys.
Richard Hatchett: Dr. Richard Hatchett, CEO of CEPI, emphasizes the urgency of developing licensed vaccines for the rapidly spreading Bundibugyo virus, stating that 'every day counts'.
May 21, 2026 · 627 articles
Accidents
International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is developing a Bundibugyo-specific version of a vaccine using a platform similar to Merck & Co.'s Ervebo vaccine, contributing to the search for a treatment.
Richard Hatchett: Richard Hatchett>>>, head of the Coalition for Epidemic Preparedness Innovations>>>, expressed high concern about the outbreak's control challenges.
May 18, 2026 · 505 articles
NEWSDESK
Explore this relationship live
Track how International AIDS Vaccine Initiative and Richard Hatchett interact across events, view sentiment trends, and discover connected entities.
Open Dashboard